Emily Chang
InvestorDirector, R&D at AOA Dx
About
Diagnostics development leader with over 12 years' experience in IVD assay development, design control, and translation of complex diagnostic programs. Brings expertise across liquid biopsy development, FDA and CLIA pathways, and multiple commercial product launches from prior roles at Thermo Fisher, Personal Genome Diagnostics, and Exact Sciences.
Colleagues at AOA Dx
Abby McElhinny
Chief Scientific Officer at AOA Dx
Alex Fisher
Chief Operating Officer & Co-Founder at AOA Dx
Anna Jeter
Chief Regulatory Officer & Co-Founder at AOA Dx
Cory Bystrom
Senior Director, Biomarker & Analytical Development at AOA Dx
Drew Watson
Clinical Advisor at AOA Dx
Elizabeth Yarber
Senior Director of Clinical Operations at AOA Dx
James White
Scientific Advisor at AOA Dx
John Friedman
Board Member at AOA Dx
Frequently asked questions
- Who is Emily Chang?
- Diagnostics development leader with over 12 years' experience in IVD assay development, design control, and translation of complex diagnostic programs. Brings expertise across liquid biopsy development, FDA and CLIA pathways, and multiple commercial product launches from prior roles at Thermo Fisher, Personal Genome Diagnostics, and Exact Sciences.
- Where does Emily Chang work?
- Emily Chang is Director, R&D at AOA Dx.